Osteopore (ASX:OSX) Short-Term Debt : A$1.16 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Osteopore Short-Term Debt?

Osteopore's Short-Term Debt for the quarter that ended in Dec. 2024 was A$1.16 Mil.

Osteopore's quarterly Short-Term Debt declined from Dec. 2023 (A$1.16 Mil) to Jun. 2024 (A$1.09 Mil) but then increased from Jun. 2024 (A$1.09 Mil) to Dec. 2024 (A$1.16 Mil).

Osteopore's annual Short-Term Debt increased from Dec. 2022 (A$0.00 Mil) to Dec. 2023 (A$1.16 Mil) but then declined from Dec. 2023 (A$1.16 Mil) to Dec. 2024 (A$1.16 Mil).

Osteopore Short-Term Debt Historical Data

The historical data trend for Osteopore's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osteopore Short-Term Debt Chart

Osteopore Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

0.43

1.16

Osteopore Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Debt	Get a 7-Day Free Trial							-	0.05	1.16	1.09	1.16

Osteopore Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Osteopore Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Osteopore's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Osteopore Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osteopore Ltd (ASX:OSX) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

191 Street Georges Terrace, Level 5, Perth, WA, AUS, 6000

Website

https://www.osteopore.com

Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.

Osteopore Headlines

No Headlines